Abeona Therapeutics Inc.
US ˙ NasdaqCM ˙ US00289Y2063

SecurityABEO / Abeona Therapeutics Inc.
InstitutionGroup One Trading, L.p.
Latest Disclosed Ownership323,986 shares
Latest Disclosed Value $ 1,707,406
Group One Trading, L.p. ownership in ABEO / Abeona Therapeutics Inc.

On February 11, 2026 - Group One Trading, L.p. filed a 13F-HR form disclosing ownership of 323,986 shares of Abeona Therapeutics Inc. (US:ABEO) valued at $1,707,406 USD as of December 31, 2025. The entity filed a previous 13F-HR on November 12, 2025 disclosing 48,000 shares of Abeona Therapeutics Inc.. This represents a change in shares of 574.97% during the quarter. The current value of the position is $1,837,001 USD.

Group One Trading, L.p. has a history of taking positions in derivatives of the underlying security (ABEO) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD and put options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

ABEO / Abeona Therapeutics Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-02-11 2025-12-31 13F ABEONA THERAPEUTICS COM NEW 00289Y206 323,986 275,986 574.97 1,707 574.70 0.0030
2025-11-12 2025-09-30 13F ABEONA THERAPEUTICS COM NEW 00289Y206 48,000 9,141 23.52 253 15.00 0.0004
2025-08-14 2025-06-30 13F ABEONA THERAPEUTICS COM NEW 00289Y206 38,859 27,470 241.20 221 307.41 0.0005
2025-05-14 2025-03-31 13F ABEONA THERAPEUTICS COM NEW 00289Y206 11,389 6,489 132.43 54 100.00 0.0002
2025-05-14 2024-12-31 13F/A-1 ABEONA THERAPEUTICS COM NEW 00289Y206 4,900 4,900 27 0.0001
2025-02-14 2024-12-31 13F ABEONA THERAPEUTICS COM NEW 00289Y206 4,900 4,900 27 0.0001
2024-11-14 2024-09-30 13F ABEONA THERAPEUTICS COM NEW 00289Y206 0 -6,283 -100.00 0 -100.00
2024-08-14 2024-06-30 13F ABEONA THERAPEUTICS COM NEW 00289Y206 6,283 4,526 257.60 27 116.67 0.0001
2024-05-10 2024-03-31 13F ABEONA THERAPEUTICS COM NEW 00289Y206 1,757 991 129.37 13 300.00 0.0000
2024-02-14 2023-12-31 13F ABEONA THERAPEUTICS COM NEW 00289Y206 766 -9,234 -92.34 4 -92.86 0.0000
2023-11-09 2023-09-30 13F ABEONA THERAPEUTICS COM NEW 00289Y206 10,000 10,000 42 0.0001
2023-02-09 2022-12-31 13F ABEONA THERAPEUTICS COM NEW 00289Y206 0 -3,497 -100.00 0 -100.00
2022-11-09 2022-09-30 13F ABEONA THERAPEUTICS COM NEW 00289Y206 3,497 3,497 11 0.0000
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2022-02-11 2021-12-31 13F ABEONA THERAPEUTICS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2021-11-12 2021-09-30 13F ABEONA THERAPEUTICS COM Call 45,700 -47.65 51 -62.50 n/a n/a n/a
2021-08-10 2021-06-30 13F ABEONA THERAPEUTICS COM Call 87,300 -43.68 136 -53.26 n/a n/a n/a
2021-05-12 2021-03-31 13F ABEONA THERAPEUTICS COM Call 155,000 1,837.50 291 2,138.46 n/a n/a n/a
2021-02-10 2020-12-31 13F ABEONA THERAPEUTICS COM Call 8,000 -27.93 13 18.18 n/a n/a n/a
2020-11-12 2020-09-30 13F ABEONA THERAPEUTICS COM Call 11,100 -12.60 11 -70.27 n/a n/a n/a
2020-08-13 2020-06-30 13F ABEONA THERAPEUTICS COM Call 12,700 -37.13 37 -11.90 n/a n/a n/a
2020-05-13 2020-03-31 13F ABEONA THERAPEUTICS COM Call 20,200 -10.62 42 -43.24 n/a n/a n/a
2020-02-10 2019-12-31 13F ABEONA THERAPEUTICS COM Call 22,600 438.10 74 722.22 n/a n/a n/a
2019-11-12 2019-09-30 13F ABEONA THERAPEUTICS COM Call 4,200 -42.47 9 -74.29 n/a n/a n/a
2019-08-09 2019-06-30 13F ABEONA THERAPEUTICS COM Call 7,300 -50.00 35 -67.29 n/a n/a n/a
2019-05-14 2019-03-31 13F/A ABEONA THERAPEUTICS COM Call 14,600 -8.75 107 -6.14 n/a n/a n/a
2019-05-13 2019-03-31 13F ABEONA THERAPEUTICS COM Call 14,600 107 n/a n/a n/a
2019-02-05 2018-12-31 13F ABEONA THERAPEUTICS COM Call 16,000 -26.61 114 -59.14 n/a n/a n/a
2018-11-08 2018-09-30 13F ABEONA THERAPEUTICS COM Call 21,800 -46.83 279 -57.47 n/a n/a n/a
2018-08-13 2018-06-30 13F ABEONA THERAPEUTICS COM Call 41,000 -42.17 656 -35.50 n/a n/a n/a
2018-05-16 2018-03-31 13F/A ABEONA THERAPEUTICS COM Call 70,900 -9.22 1,017 -17.85 n/a n/a n/a
2018-05-10 2018-03-31 13F ABEONA THERAPEUTICS COM Call 70,900 1,017 n/a n/a n/a
2018-02-09 2017-12-31 13F ABEONA THERAPEUTICS COM Call 78,100 29.52 1,238 20.43 n/a n/a n/a
2017-11-15 2017-09-30 13F ABEONA THERAPEUTICS COM Call 60,300 996.36 1,028 2,837.14 n/a n/a n/a
2017-08-14 2017-06-30 13F ABEONA THERAPEUTICS COM Call 5,500 35 n/a n/a n/a
2017-05-10 2017-03-31 13F ABEONA THERAPEUTICS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2017-02-15 2016-12-31 13F ABEONA THERAPEUTICS COM Call 1,000 5 n/a n/a n/a
2016-02-11 2015-12-31 13F ABEONA THERAPEUTICS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2015-11-20 2015-09-30 13F/A ABEONA THERAPEUTICS COM Call 3,100 0.00 13 -18.75 n/a n/a n/a
2015-11-06 2015-09-30 13F ABEONA THERAPEUTICS COM Call 3,100 13 n/a n/a n/a
2015-08-11 2015-06-30 13F ABEONA THERAPEUTICS COM Call 3,100 16 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2021-11-12 2021-09-30 13F ABEONA THERAPEUTICS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2021-08-10 2021-06-30 13F ABEONA THERAPEUTICS COM Put 20,600 -69.16 32 -74.60 n/a n/a n/a
2021-05-12 2021-03-31 13F ABEONA THERAPEUTICS COM Put 66,800 126 n/a n/a n/a
2020-11-12 2020-09-30 13F ABEONA THERAPEUTICS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2020-08-13 2020-06-30 13F ABEONA THERAPEUTICS COM Put 500 -66.67 1 -66.67 n/a n/a n/a
2020-05-13 2020-03-31 13F ABEONA THERAPEUTICS COM Put 1,500 -92.46 3 -95.38 n/a n/a n/a
2020-02-10 2019-12-31 13F ABEONA THERAPEUTICS COM Put 19,900 314.58 65 490.91 n/a n/a n/a
2019-11-12 2019-09-30 13F ABEONA THERAPEUTICS COM Put 4,800 -82.22 11 -91.47 n/a n/a n/a
2019-08-09 2019-06-30 13F ABEONA THERAPEUTICS COM Put 27,000 -4.26 129 -37.98 n/a n/a n/a
2019-05-14 2019-03-31 13F/A ABEONA THERAPEUTICS COM Put 28,200 -35.32 208 -33.12 n/a n/a n/a
2019-05-13 2019-03-31 13F ABEONA THERAPEUTICS COM Put 28,200 208 n/a n/a n/a
2019-02-05 2018-12-31 13F ABEONA THERAPEUTICS COM Put 43,600 46.31 311 -18.37 n/a n/a n/a
2018-11-08 2018-09-30 13F ABEONA THERAPEUTICS COM Put 29,800 13.74 381 -9.07 n/a n/a n/a
2018-08-13 2018-06-30 13F ABEONA THERAPEUTICS COM Put 26,200 7.82 419 20.06 n/a n/a n/a
2018-05-16 2018-03-31 13F/A ABEONA THERAPEUTICS COM Put 24,300 -54.83 349 -59.09 n/a n/a n/a
2018-05-10 2018-03-31 13F ABEONA THERAPEUTICS COM Put 24,300 349 n/a n/a n/a
2018-02-09 2017-12-31 13F ABEONA THERAPEUTICS COM Put 53,800 73.55 853 61.25 n/a n/a n/a
2017-11-15 2017-09-30 13F ABEONA THERAPEUTICS COM Put 31,000 529 n/a n/a n/a
2016-02-11 2015-12-31 13F ABEONA THERAPEUTICS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2015-11-20 2015-09-30 13F/A ABEONA THERAPEUTICS COM Put 5,800 0.00 23 -20.69 n/a n/a n/a
2015-11-06 2015-09-30 13F ABEONA THERAPEUTICS COM Put 5,800 23 n/a n/a n/a
2015-08-11 2015-06-30 13F ABEONA THERAPEUTICS COM Put 5,800 29 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.